So, you can see that when you have a cold, or flu you are fighting a virus, or bacteria. To lessen the period, and strength of these conditions, your immune system has to be strong. You don’t want a cold or flu to turn into pneumonia, or any other respiratory condition.
A weaponized deadly virus brings the GhostWalkers to Sumutra in the hope they can save the doctors trying to identify it and stop the spread of the virus. As the team exits Draden is shot with a dart full of the deadly virus and must stay behind...to die.
Shylah is out to stop the dangerous men making the virus when she sees Draden. In her attempt to save him, she is exposed as well.
When you have only days to live, you live them unlike any that you've ever known. You fight harder. You love easier. And you hope to go out with integrity and honor.
But, Draden's team has other plans. Their biggest enemy is now time.
Find out more at https://www.christinefeehan.com/ Military romance/paranormal romance
A weaponized deadly virus brings the GhostWalkers to Sumutra in the hope they can save the doctors trying to identify it and stop the spread of the virus. As the team exits Draden is shot with a dart full of the deadly virus and must stay behind...to die.
Shylah is out to stop the dangerous men making the virus when she sees Draden. In her attempt to save him, she is exposed as well.
When you have only days to live, you live them unlike any that you've ever known. You fight harder. You love easier. And you hope to go out with integrity and honor.
But, Draden's team has other plans. Their biggest enemy is now time.
Find out more at https://www.christinefeehan.com/ Military romance/paranormal romance
A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma.
The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor.
To view the multimedia release go to:
https://www.multivu.com/players/English/7944251-northwestern-medicine-stem-cell-trial/
TruGreen, the nation’s leading professional lawn care company helping people live life outside, is expanding its expert service offerings with the launch of TruGreen Mosquito Defense to help homeowners combat mosquitoes and help protect their families.
As the weather gets warmer, these backyard invaders can prevent homeowners from reaping the benefits of living life outside. According to a recent online survey conducted by Harris Poll on behalf of TruGreen, among over 2,000 U.S. adults, 85 percent of Americans say that mosquitoes limit their or their family’s outdoor activities during the months they’re most active. The same survey also found that nearly two thirds of Americans (64 percent) are concerned about protecting themselves and their family from Zika or other mosquito-borne illnesses. Furthermore, 65 percent of Americans use bug spray on themselves/their family to combat mosquitoes outdoors at home and though it’s the top response for preventative measures, still only half (51 percent) say it is most effective at preventing mosquitoes from biting outdoors at home.
To view the multimedia release go to:
https://www.multivu.com/players/English/8090051-trugreen-mosquito-defense-lawn-yard-care/
Richard Dawkins gençlere yönelik olarak Evren, Dünya, canlılar ve diğer birçok konuya ilişkin sorulara bilimle cevap verdiği son kitabı The Magic of Reality'deki "İlk İnsan Kimdi?" adlı bölümde bahsi geçen, gözle görülemeyen evrimi (diğer bir deyişle bakteri ve virüslerdeki kadar hızlı görülmeyen) kavrayabilmemiz için bir düşünce deneyi gerçekleştiriyor. Evrim sürekli devam eden bir süreç. Bu yüzden milyonlarca yıllık bir ağaç üzerinde sadece belli duraklardaki dallara bakarak çeşitli isimler veriyoruz: Homo sapiens (modern insan), Homo erectus, Homo neanderthalensis gibi... Hepsi bu zincirin bir devamı olduğundan ilk insan kimdi sorusu da anlamını yitiriyor. Önce bebek, sonra çocuk, sonra yetişkin, en sonunda da yaşlanmamız gibi bu kesintisiz süreç hep devam ediyor ve bebeklik, çocukluk vs. diye adlandırdığımız, ancak kendimizde göremediğimiz bu aşamaları fotoğraf karelerine aldığımızda bir ayrım yapabiliyoruz ancak.
Kitap bir yayınevi tarafından henüz Türkçe'ye çevrilme aşamasında.
Bu videoyu seyrederken dehşete düştüm, tanrı evrimi kanıtlamak için hem şempanzelerin hem de insanların DNA'larına 16 yerden ERV (virüsten kaynaklanan hata) yerleştirmiş. Buna inanmak mı daha kolay, yoksa bu hataların ortak atamızdan her iki türe de geçtiği mi akla daha yakın. İzleyin, olasılıkları görün ve kendiniz karar verin.
http://materyalistceseyler.wordpress.com/
Where might be the perfect place to introduce Tecnu Bites & Stings, an aptly named new over-the-counter product for stings and insect bites? How about the Great Texas Mosquito Festival in Clute, Texas? For 36 years, thousands of people have gathered at the yearly celebration along the gulf coast of Texas; a place known for thirsty mosquitoes, biting ants and other persnickety pests.
To the group at Tec Labs it sounded like the perfect place to get credible feedback on their innovative new product. So they hired a professional camera crew, grabbed some cases of Tecnu Bites & Stings and left the humidity-free confines of Oregon and headed to the land of cowgirls and Texas tea.
As the camera rolled, the video crew got some wonderful feedback from a great mix of people. The goal was to get honest and straightforward reactions and that’s exactly what occurred. Texans love straight talk and Tec Labs was thrilled to get the feedback. See the authentic reactions for yourself by watching the video!
To view the multimedia release go to:
http://www.multivu.com/players/English/7912451-tecnu-insect-bites-stings-wipes/
The Level 3 Threat Research Labs, Level 3 Communications' (LVLT) threat intelligence and research arm, unveiled new research about the botnet size and behavior for the malware commonly referred to as Lizkebab, BASHLITE, Torlus or gafgyt, including botnet size and victim stats.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911451-level-3-threat-research-malware/
Seqirus is now shipping its complete portfolio of seasonal influenza vaccines to customers in the US market for the 2016-2017 season. Seqirus is the only influenza vaccine manufacturer to produce influenza vaccines using both egg-based and cell culture technologies, and the only provider in the US that offers both quadrivalent and trivalent influenza vaccines, as well as the only adjuvanted seasonal influenza vaccine.
Seqirus is now shipping to the US all influenza vaccines in its portfolio, including Fluad™ (Influenza Vaccine, Adjuvanted), Flucelvax Quadrivalent™ (Influenza Vaccine), Afluria® (Influenza Vaccine), and Fluvirin® (Influenza Virus Vaccine) in advance of the peak of influenza season.
“Seqirus is proud to be a major contributor to the prevention and control of influenza by offering healthcare providers and pharmacists with a range of clinically proven, innovative vaccination options that help protect people against the debilitating effects of the disease,” said Brent MacGregor, Senior Vice President, Commercial Operations. “We are committed to being an early and reliable supplier of our influenza vaccines to help ensure that appropriate patients have plenty of time to get their annual immunization.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7902351-seqirus-franchise-shipment/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2016-2017 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA) for shipment. This represents the first of more than 65 million total doses of seasonal influenza vaccine manufactured by Sanofi Pasteur that will be delivered to U.S. health care providers and pharmacies beginning in July and continuing throughout the remainder of the year. Sanofi Pasteur plans to increase its supply to respond to the shifting pediatric public health needs.
Seasonal influenza activity typically occurs between October and May and peaks between December and February. However, influenza activity peaked noticeably late last season occurring in early March 2016.1 Influenza seasons are always unpredictable as new influenza strains emerge and strain activity fluctuates throughout the year, making timely vaccination even more important to help protect against the virus, especially for seniors, young children and infants six months of age and older.
To view the multimedia release go to:
http://www.multivu.com/players/English/7842051-sanofi-pasteur-influenza-vaccine/
